Armistice Capital, LLC Axogen, Inc. Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 613,000 shares of AXGN stock, worth $10.9 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
613,000
Previous 400,055
53.23%
Holding current value
$10.9 Million
Previous $5.61 Million
80.14%
% of portfolio
0.14%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$79.9 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$57.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$52.4 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$43.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$43 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $749M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...